清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

A randomized controlled trial comparing medical and expectant management of first trimester miscarriage

作者
J.S. Bagratee
出处
期刊:Human Reproduction [Oxford University Press]
卷期号:19 (2): 266-271 被引量:165
标识
DOI:10.1093/humrep/deh049
摘要

BACKGROUND: We aimed to determine whether outpatient treatment of miscarriage with vaginal misoprostol is more effective than expectant management in reducing the need for surgical evacuation of retained products of conception (ERPC). METHODS: Of 131 eligible women with first trimester miscarriage, 104 agreed to randomization to either 600 microg misoprostol or placebo intravaginally. They were assessed the following day and administered a second dose of their allocated treatment if miscarriage was not complete. Those not successful after two doses were seen on day 7, and, if miscarriage was not complete, an ERPC was performed. RESULTS: The success rate of medical management was 88.5% (46/52) compared with 44.2% (23/52) for expectant management. There was no significant difference in success rate (100 versus 85.7%) in women treated with an incomplete miscarriage. Women with early pregnancy failure had a success rate of 87% with misoprostol compared with 29% with expectant management [odds ratio (OR) 15.96; 95% confidence interval (CI) 5.26, 48.37]. The complete miscarriage rate was achieved quicker in the medical group than the expectant group by day 1 (32.7 versus 5.8%) and by day 2 (73.1 versus 13.5%) of treatment. There were no differences in side-effects, bleeding duration, analgesia use, pain score and satisfaction with treatment. Women in the expectant group made more outpatient visits (5.06 versus 4.44%; OR = -0.62, 95% CI -1.04, -0.19). More women in the medical group (90.4 versus 73.1%; OR 1.26, 95% CI 1.05, 1.50) would elect the same treatment in the future. CONCLUSIONS: Medical management using 600 microg misoprostol vaginally is more effective than expectant management of early pregnancy failure. Misoprostol did not increase the side-effect profile and patient acceptability was superior to expectant management.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顶刊相见发布了新的文献求助10
2秒前
廖道罡完成签到,获得积分10
9秒前
专注寒蕾完成签到,获得积分10
11秒前
18秒前
H1lb2rt完成签到 ,获得积分10
25秒前
精明凝海发布了新的文献求助10
26秒前
wcl完成签到,获得积分10
33秒前
小黄完成签到 ,获得积分10
33秒前
精明的彩虹完成签到,获得积分10
34秒前
高高的玉兰完成签到,获得积分10
40秒前
45秒前
微笑妖丽完成签到,获得积分10
51秒前
qin完成签到 ,获得积分10
54秒前
mzhang2完成签到 ,获得积分10
1分钟前
wwwwwnnnnn完成签到 ,获得积分10
1分钟前
英俊的铭的应助被科研通管家采纳,获得10
1分钟前
1分钟前
沙海沉戈完成签到,获得积分0
1分钟前
彩色听筠完成签到,获得积分10
1分钟前
复杂的雁芙完成签到,获得积分10
1分钟前
领导范儿的应助被BYL采纳,获得10
1分钟前
1分钟前
成就云朵完成签到,获得积分10
1分钟前
2分钟前
晓晓完成签到,获得积分10
2分钟前
晓晓发布了新的文献求助10
2分钟前
lulu完成签到,获得积分10
2分钟前
韦韦完成签到 ,获得积分10
2分钟前
李木禾完成签到 ,获得积分10
2分钟前
vbnn完成签到 ,获得积分10
2分钟前
2分钟前
Husile发布了新的文献求助10
2分钟前
迷人悒完成签到,获得积分10
2分钟前
huluwa完成签到,获得积分10
2分钟前
2分钟前
YZY完成签到 ,获得积分10
2分钟前
2分钟前
坚强冷荷完成签到,获得积分10
2分钟前
风中碧菡完成签到,获得积分10
2分钟前
BYL发布了新的文献求助10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179980
求助须知:如何正确求助?哪些是违规求助? 9570196
关于积分的说明 21808506
捐赠科研通 7775966
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557389
邀请新用户注册赠送积分活动 2478998